{"id":"https://openalex.org/W4311396160","doi":"https://doi.org/10.1016/j.fander.2022.09.578","title":"Efficacit\u00e9 et tol\u00e9rance de l\u2019abrocitinib selon le poids corporel : analyse pool\u00e9e de 3 essais cliniques randomis\u00e9s","display_name":"Efficacit\u00e9 et tol\u00e9rance de l\u2019abrocitinib selon le poids corporel : analyse pool\u00e9e de 3 essais cliniques randomis\u00e9s","publication_year":2022,"publication_date":"2022-11-01","ids":{"openalex":"https://openalex.org/W4311396160","doi":"https://doi.org/10.1016/j.fander.2022.09.578"},"language":"fr","primary_location":{"id":"doi:10.1016/j.fander.2022.09.578","doi":"https://doi.org/10.1016/j.fander.2022.09.578","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.fander.2022.09.578","pdf_url":null,"source":{"id":"https://openalex.org/S4210216760","display_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie - FMC","issn_l":"2667-0623","issn":["2667-0623","2667-0631"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie - FMC","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5083096193","display_name":"J.P. Thyssen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I124055696","display_name":"University of Copenhagen","ror":"https://ror.org/035b05819","country_code":"DK","type":"education","lineage":["https://openalex.org/I124055696"]},{"id":"https://openalex.org/I2801941904","display_name":"Bispebjerg Hospital","ror":"https://ror.org/00td68a17","country_code":"DK","type":"healthcare","lineage":["https://openalex.org/I2801941904","https://openalex.org/I2802567020"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"J.P. Thyssen","raw_affiliation_strings":["Bispebjerg hospital, University of Copenhagen, Copenhague, Danemark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bispebjerg hospital, University of Copenhagen, Copenhague, Danemark","institution_ids":["https://openalex.org/I124055696","https://openalex.org/I2801941904"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011741828","display_name":"Jonathan I. Silverberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I193531525","display_name":"George Washington University","ror":"https://ror.org/00y4zzh67","country_code":"US","type":"education","lineage":["https://openalex.org/I193531525"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Silverberg","raw_affiliation_strings":["The George Washington University School of Medicine and Health Sciences, Washington, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The George Washington University School of Medicine and Health Sciences, Washington, \u00c9tats-Unis","institution_ids":["https://openalex.org/I193531525"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026963044","display_name":"Michael J. Cork","orcid":"https://orcid.org/0000-0003-4428-2428","observed_orcids":["https://orcid.org/0000-0003-4428-2428"]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M.J. Cork","raw_affiliation_strings":["Sheffield dermatology research, University of Sheffield, Sheffield, Royaume-Uni"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sheffield dermatology research, University of Sheffield, Sheffield, Royaume-Uni","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044707511","display_name":"A. Taieb","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"A. Taieb","raw_affiliation_strings":["Centre hospitalier universitaire, Universit\u00e9 de Bordeaux, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre hospitalier universitaire, Universit\u00e9 de Bordeaux, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066578368","display_name":"B.K. Malhotra","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B.K. Malhotra","raw_affiliation_strings":["Pharmacologie clinique, Pfizer Inc., New York, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacologie clinique, Pfizer Inc., New York, \u00c9tats-Unis","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028163429","display_name":"S.L. Johnson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.L. Johnson","raw_affiliation_strings":["Wsr-safety, Pfizer Inc., Raleigh-Durham, NC, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Wsr-safety, Pfizer Inc., Raleigh-Durham, NC, \u00c9tats-Unis","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031466135","display_name":"L. Fostvedt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"L. Fostvedt","raw_affiliation_strings":["Pharmacologie, Pfizer Inc., Cambridge, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacologie, Pfizer Inc., Cambridge, \u00c9tats-Unis","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043929271","display_name":"C. Feeney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189718659","display_name":"Pfizer (United Kingdom)","ror":"https://ror.org/04x4v8p40","country_code":"GB","type":"company","lineage":["https://openalex.org/I180857899","https://openalex.org/I189718659"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Feeney","raw_affiliation_strings":["M\u00e9dical global, Pfizer Ltd, Surrey, Royaume-Uni"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M\u00e9dical global, Pfizer Ltd, Surrey, Royaume-Uni","institution_ids":["https://openalex.org/I189718659"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040811689","display_name":"P. Biswas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Biswas","raw_affiliation_strings":["Biostatistique, Pfizer Inc., New York, \u00c9tats-Unis"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Biostatistique, Pfizer Inc., New York, \u00c9tats-Unis","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":8,"corresponding_author_ids":["https://openalex.org/A5044707511"],"corresponding_institution_ids":["https://openalex.org/I15057530","https://openalex.org/I3018323443"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"2","issue":"8","first_page":"A342","last_page":"A343"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9970999956130981,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10051","display_name":"Asthma and respiratory diseases","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10877","display_name":"Allergic Rhinitis and Sensitization","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2723","display_name":"Immunology and Allergy"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abrocitinib","display_name":"abrocitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/atopic-dermatitis","display_name":"atopic dermatitis","score":0.9279999732971191},{"id":"https://openalex.org/keywords/jak1-inhibitor","display_name":"JAK1 inhibitor","score":0.7239999771118164},{"id":"https://openalex.org/keywords/body-weight","display_name":"body weight","score":0.925000011920929},{"id":"https://openalex.org/keywords/body-mass-index","display_name":"body mass index","score":0.9990000128746033},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.3479999899864197},{"id":"https://openalex.org/keywords/efficacy","display_name":"efficacy","score":0.35600000619888306},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.8920000195503235},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.46799999475479126},{"id":"https://openalex.org/keywords/pooled-analysis","display_name":"pooled analysis","score":0.546999990940094},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.5040000081062317},{"id":"https://openalex.org/keywords/monotherapy","display_name":"monotherapy","score":0.4659999907016754},{"id":"https://openalex.org/keywords/iga-response","display_name":"IgA antibody response","score":0.3619999885559082},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.4950000047683716},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.4020000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3963412642478943},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.3869086802005768}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.fander.2022.09.578","doi":"https://doi.org/10.1016/j.fander.2022.09.578","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.fander.2022.09.578","pdf_url":null,"source":{"id":"https://openalex.org/S4210216760","display_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie - FMC","issn_l":"2667-0623","issn":["2667-0623","2667-0631"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie - FMC","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3215504594","https://openalex.org/W3211528735","https://openalex.org/W4404368689","https://openalex.org/W4394772967","https://openalex.org/W4388759796","https://openalex.org/W7154298568","https://openalex.org/W4389657062","https://openalex.org/W3216822956","https://openalex.org/W3206309283","https://openalex.org/W4311383305"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-12-26T00:00:00"}